Latest Insider Transactions at Unity Biotechnology, Inc. (UBX)
This section provides a real-time view of insider transactions for Unity Biotechnology, Inc. (UBX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Unity Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Unity Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2024
|
Lynne Marie Sullivan CFO & Head of Corp. Dev. |
SELL
Open market or private sale
|
Direct |
324
-0.98%
|
$324
$1.4 P/Share
|
|
Jun 25
2024
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,214
-1.55%
|
$1,214
$1.4 P/Share
|
|
Jun 25
2024
|
Alexander Hieu Nguyen Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
78
-0.31%
|
$78
$1.4 P/Share
|
|
May 02
2024
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
603
-0.77%
|
$603
$1.55 P/Share
|
|
Mar 26
2024
|
Alexander Hieu Nguyen Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+44.34%
|
-
|
|
Feb 02
2024
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
680
-0.86%
|
$680
$1.71 P/Share
|
|
Jan 30
2024
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,183
-1.47%
|
$1,183
$1.71 P/Share
|
|
Nov 02
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
589
-0.73%
|
$589
$1.83 P/Share
|
|
Oct 30
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,024
-1.25%
|
$1,024
$1.9 P/Share
|
|
Sep 14
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,246
-1.49%
|
$2,492
$2.47 P/Share
|
|
Aug 02
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
581
-0.69%
|
$1,162
$2.94 P/Share
|
|
Jul 31
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,020
-1.2%
|
$2,040
$2.86 P/Share
|
|
Jun 26
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,177
-1.36%
|
$3,531
$3.2 P/Share
|
|
Jun 14
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,212
-1.39%
|
$3,636
$3.39 P/Share
|
|
May 02
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
588
-0.67%
|
$1,176
$2.17 P/Share
|
|
May 01
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,020
-92.06%
|
$2,040
$2.15 P/Share
|
|
Mar 31
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,959
-2.15%
|
$1,959
$1.7 P/Share
|
|
Mar 31
2023
|
Jamie Dananberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
420
-0.66%
|
$420
$1.7 P/Share
|
|
Mar 14
2023
|
Jamie Dananberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,005
-1.56%
|
$4,020
$4.0 P/Share
|
|
Mar 14
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,210
-1.31%
|
$4,840
$4.0 P/Share
|
|
Feb 02
2023
|
Jamie Dananberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
863
-1.33%
|
$3,452
$4.84 P/Share
|
|
Feb 02
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,573
-2.71%
|
$10,292
$4.84 P/Share
|
|
Jan 30
2023
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,140
-1.19%
|
$4,560
$4.45 P/Share
|
|
Dec 14
2022
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,274
-1.31%
|
$2,548
$2.85 P/Share
|
|
Dec 14
2022
|
Jamie Dananberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,016
-1.54%
|
$2,032
$2.85 P/Share
|
|
Nov 03
2022
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,099
-1.12%
|
$2,198
$2.4 P/Share
|
|
Sep 14
2022
|
Jamie Dananberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,923
-1.63%
|
$0
$0.48 P/Share
|
|
Sep 14
2022
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,706
-1.37%
|
$0
$0.48 P/Share
|
|
Aug 01
2022
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,446
-1.04%
|
$0
$0.67 P/Share
|
|
Jun 27
2022
|
Anirvan Ghosh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,149
-1.19%
|
$0
$0.59 P/Share
|
|
Jun 27
2022
|
Jamie Dananberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,398
-0.65%
|
$0
$0.59 P/Share
|
|
Jun 21
2022
|
Jamie Dananberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,697
-0.54%
|
$0
$0.62 P/Share
|
|
Jun 14
2022
|
Jamie Dananberg Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,530
-1.52%
|
$0
$0.63 P/Share
|
|
Jun 14
2022
|
Anirvan Ghosh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,683
-1.23%
|
$0
$0.63 P/Share
|
|
May 15
2022
|
Lynne Marie Sullivan CFO & Head of Corp. Dev. |
BUY
Other acquisition or disposition
|
Direct |
925
+2.73%
|
$5,550
$6.89 P/Share
|
|
May 02
2022
|
Anirvan Ghosh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,729
-0.74%
|
$0
$0.88 P/Share
|
|
Mar 31
2022
|
Jamie Dananberg Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,188
-0.6%
|
$4,188
$1.14 P/Share
|
|
Mar 31
2022
|
Anirvan Ghosh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,472
-1.37%
|
$14,472
$1.14 P/Share
|
|
Mar 14
2022
|
Jamie Dananberg Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,581
-1.5%
|
$0
$0.88 P/Share
|
|
Mar 14
2022
|
Anirvan Ghosh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,272
-0.87%
|
$0
$0.88 P/Share
|
|
Feb 09
2022
|
Anirvan Ghosh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
141,667
+11.75%
|
-
|
|
Feb 09
2022
|
Lynne Marie Sullivan CFO & Head of Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+13.27%
|
-
|
|
Feb 09
2022
|
Alexander Hieu Nguyen Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,833
+47.31%
|
-
|
|
Feb 09
2022
|
Jamie Dananberg Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,833
+6.1%
|
-
|
|
Dec 14
2021
|
Jamie Dananberg Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,614
-1.58%
|
$10,614
$1.63 P/Share
|
|
Jun 24
2021
|
Anirvan Ghosh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,000
+7.24%
|
-
|
|
Jun 24
2021
|
Jamie Dananberg Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+3.4%
|
-
|
|
Jun 24
2021
|
Lynne Marie Sullivan CFO & Head of Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
30,833
+10.22%
|
-
|
|
Jun 24
2021
|
Alexander Hieu Nguyen Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+50.0%
|
-
|
|
Jun 21
2021
|
Jamie Dananberg Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,515
-0.51%
|
$14,060
$4.18 P/Share
|